These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 31404620)

  • 1. Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults.
    Welte T; Kantecki M; Stone GG; Hammond J
    Int J Antimicrob Agents; 2019 Oct; 54(4):410-422. PubMed ID: 31404620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
    Lodise TP; Low DE
    Drugs; 2012 Jul; 72(11):1473-93. PubMed ID: 22779432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.
    Frampton JE
    Drugs; 2013 Jul; 73(10):1067-94. PubMed ID: 23801418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ceftaroline fosamil in community-acquired and nosocomial pneumonia].
    Calbo E; Zaragoza R
    Enferm Infecc Microbiol Clin; 2014 Mar; 32 Suppl 2():38-43. PubMed ID: 24702978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
    Jorgenson MR; DePestel DD; Carver PL
    Ann Pharmacother; 2011 Nov; 45(11):1384-98. PubMed ID: 22009993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant
    Torres A; Kuraieva A; Stone GG; Cillóniz C
    Eur Respir Rev; 2023 Dec; 32(170):. PubMed ID: 37852658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftaroline Fosamil: A Review in Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.
    Scott LJ
    Drugs; 2016 Nov; 76(17):1659-1674. PubMed ID: 27766567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftaroline fosamil for treatment of community-acquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapy.
    DiMondi VP; Drew RH; Chen LF
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):567-72. PubMed ID: 21819323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone.
    Cannavino CR; Nemeth A; Korczowski B; Bradley JS; O'Neal T; Jandourek A; Friedland HD; Kaplan SL
    Pediatr Infect Dis J; 2016 Jul; 35(7):752-9. PubMed ID: 27093162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of ceftaroline fosamil microbiology: integrated FOCUS studies.
    Critchley IA; Eckburg PB; Jandourek A; Biek D; Friedland HD; Thye DA
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii45-51. PubMed ID: 21482569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus.
    Zhanel GG; Sniezek G; Schweizer F; Zelenitsky S; Lagacé-Wiens PR; Rubinstein E; Gin AS; Hoban DJ; Karlowsky JA
    Drugs; 2009; 69(7):809-31. PubMed ID: 19441869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
    File TM; Low DE; Eckburg PB; Talbot GH; Friedland HD; Lee J; Llorens L; Critchley IA; Thye DA;
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii19-32. PubMed ID: 21482566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection.
    Casapao AM; Steed ME; Levine DP; Rybak MJ
    Expert Opin Pharmacother; 2012 Jun; 13(8):1177-86. PubMed ID: 22594846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Ceftaroline Fosamil in Osteomyelitis: CAPTURE Study Experience.
    Johnson LB; Ramani A; Guervil DJ
    BMC Infect Dis; 2019 Feb; 19(1):183. PubMed ID: 30791894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
    Low DE; File TM; Eckburg PB; Talbot GH; David Friedland H; Lee J; Llorens L; Critchley IA; Thye DA;
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii33-44. PubMed ID: 21482568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftaroline fosamil for community-acquired pneumonia and skin and skin structure infections: a systematic review.
    El Hajj MS; Turgeon RD; Wilby KJ
    Int J Clin Pharm; 2017 Feb; 39(1):26-32. PubMed ID: 28058593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.
    Esposito S; Carrothers TJ; Riccobene T; Stone GG; Kantecki M
    Paediatr Drugs; 2021 Nov; 23(6):549-563. PubMed ID: 34462863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftaroline fosamil: a novel broad-spectrum cephalosporin.
    Bazan JA; Martin SI
    Drugs Today (Barc); 2010 Oct; 46(10):743-55. PubMed ID: 21076711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens.
    Steed ME; Rybak MJ
    Pharmacotherapy; 2010 Apr; 30(4):375-89. PubMed ID: 20334458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftaroline fosamil: a new broad-spectrum cephalosporin.
    Laudano JB
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii11-8. PubMed ID: 21482565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.